growth in china and cochlear, page-37

pbi v vcr

gees fellas, have just been reading the ventracor thread and reading some of their past announcements .... to me PBI has much more going for it than this mob ... sure they will ultimately have a great product and market, but PBI's pulmosonix range has a far clearer path to market in a much shorter time frame and i would venture just as big an impact on public health .... vcr capped at $240m and trading mid .70's+ ... pbi has 60m shares and trading at .21.

crikey ... this company needs some proper PR and marketing to funds to come in and push it ...